Evidence map›Paper›PMID 31186381›Full record

ArticleAging2019

Knockdown of angiopoietin-like 2 induces clearance of vascular endothelial senescent cells by apoptosis, promotes endothelial repair and slows atherogenesis in mice.

Laurie Caland, Pauline Labbé, Maya Mamarbachi, Louis Villeneuve, Gerardo Ferbeyre, Pierre-Emmanuel Noly, Michel Carrier, Nathalie Thorin-Trescases, Éric Thorin

Open access · greenAbstract read
In one paragraph

Article in Aging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Laurie CalandFaculty of Medicine, Department of Pharmacology and Physiology, Université de Montréal, Montreal, Quebec, Canada.
Pauline LabbéFaculty of Medicine, Department of Pharmacology and Physiology, Université de Montréal, Montreal, Quebec, Canada.
Maya MamarbachiMontreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada.
Louis VilleneuveMontreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada.
Gerardo FerbeyreFaculty of Medicine, Department of Biochemistry, Université de Montréal and CRCHUM, Montreal, Quebec, Canada.
Pierre-Emmanuel NolyMontreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada.
Michel CarrierMontreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada.
Nathalie Thorin-TrescasesMontreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada.
Éric ThorinMontreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada.
Université de Montréal · CAMontreal Heart Institute · CA

Funding

Canadian Institute for Health Research MOP133649
6 · The paper itself

Abstract

Elimination of senescent cells (SnC) is anti-atherogenic, but the specific contribution of senescent vascular endothelial cells (EC) is unknown. We inactivated angiopoietin like-2 (angptl2), a marker of SnEC and a pro-atherogenic cytokine in LDLr

Indexed as

AgedAngiopoietin-Like Protein 2Angiopoietin-like ProteinsAnimalsAorta, ThoracicApoptosisAtherosclerosisCellular SenescenceCoronary Artery DiseaseDisease Models, AnimalDisease ProgressionEndothelial CellsEndothelium, VascularFemaleHumansMaleAngiopoietin-Like Protein 2Angiopoietin-like ProteinsAngptl2 protein, mouseBax/Bcl2CD34human internal mammary arteryp21PAI-1

Identifiers

PMID31186381
PMCPMC6594793
OpenAlexW2949400953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.